Last reviewed · How we verify
NCT05506306: VERTEXO
Multitissular Effect of Vertical Mobilization Using the Exoskeleton AtalanteTM in Neurological Chair- or Bed-bound Patients
trial testing Assessment in Neurologic Disorder in 30 participants. Status unknown.
1 September 2023
Quick facts
| Lead sponsor | Henri Mondor University Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 1 September 2022 |
| Primary completion | 1 September 2023 |
| Estimated completion | 1 September 2024 |
Drugs / interventions tested
- Assessment
Conditions studied
- Neurologic Disorder — all drugs for Neurologic Disorder →
Sponsor
Henri Mondor University Hospital
Who can join
18 and older, any sex, with Neurologic Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background and aim: Sustained bed rest impairs many bodily functions. Verticalization restores gravitational challenge and the use of several organs. The Atalante™ exoskeleton (Wandercraft) is the only self-balanced exoskeleton, which allows walking without canes. We assessed multi-tissular effects of mobile reverticalization using Atalante™ in neurological bed- or wheelchair-bound patients. Methods: Observational cohort study. Inclusion criteria: bed- or wheelchair-bound for \>2 weeks and \<1 hour per day of stance, due to a central neurological disorder. Sessions with exoskeleton were 3/week, integrated in routine care. Data collected at baseline and after eight weeks (W8) included: cardiovascular (echocardiography, EKG, blood pressure lying and standing), pulmonary (spirometry), bone (densitometry, biochemical markers), bowels (daily stool frequency, Bristol Stool Scale), urinary (urinary flow, postmictional residual volume, urinary symptom profile questionnaire, USP), cognitive (trail making test, TMT-B), anxiety and depression (HAD), and quality of life (SF12). Results will be presented at the end of the study.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Safety and efficacy of the Atalante exoskeleton in the rehabilitation of French patients with amyotrophic lateral sclerosis: a prospective, monocentric, open, uncontrolled, interventional protocol, EXALS.
Trad G, Lenglet T, Ledoux I, Querin G, et al · · 2026 · PMID 41545051 · DOI 10.1136/bmjopen-2025-109620
Verify or expand the search:
- PubMed search for NCT05506306
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Assessment
Trials testing the same drug.
- NCT07520981 — Functional Capacity, Subjective Dyspnea and Fatigue in Smokers · not yet recruiting
- NCT07225920 — Understanding Needs of Older Patients Prior to Starting Cancer Treatment · NA · enrolling by invitation
- NCT07249541 — Hypermobility, Foot Posture, and Scoliosis Severity · not yet recruiting
- NCT07256873 — Validity and Reliability of Face-to-Face and Tele-Assessment of Core Stability and Functional Capacity · completed
- NCT07249515 — Scapula and Upper Extremity Performance in Scoliosis · recruiting
Other recruiting trials for Neurologic Disorder
Currently open trials in the same condition.
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT06208332 — The "What Is Important to Us" Communication Intervention Pilot Clinical Trial · Phase 2 · recruiting
- NCT06750692 — Comparison of the Effects of Mirror Therapy,rTMS and Robotic-assisted Hand Therapy in Stroke Patients · NA · recruiting
- NCT06883227 — Investigating Health Impacts of Exposure to Harmful Algal Blooms · recruiting
- NCT06523270 — Advanced Imaging Holistic Omics Biobank · recruiting
Other Henri Mondor University Hospital trials
Trials by the same sponsor.
- NCT06107556 — Agonist and Antagonist Muscle Activations in the Lower Limbs During Walking After Central Nervous System Injury · unknown
- NCT05998473 — Characterization of Dynamic Stability in Normal Pressure Hydrocephalus and Parkinson's Disease · unknown
- NCT05998486 — Detecting the Rest Tremor Associated With Parkinson's Disease Using Analysis of the Muscle Contractions Rhythmicity · unknown
- NCT05519592 — Proximal Lower Limb Intramuscular Block : Effects on Hemiparetic Gait · NA · unknown
- NCT05350995 — Evaluation of Antibiotherapy Prescribed for Outpatients From Emergency Departments · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05506306 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Henri Mondor University Hospital
- Last refreshed: 18 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05506306.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing